Related Experiment Video
Updated: Aug 26, 2026

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA
Published on: December 15, 2023
Prevalence of hepatitis C virus among bilharziasis patients
Zaheer A Khan1, Ibrahim S Alkhalife, Sami E Fathalla
1Department of Parasitology, Damman Regional Laboratory and Blood Bank, Kingdom of Saudi Arabia. zaheerahmedkhan@hotmail.com
Insights
Hepatitis C virus (HCV) infection is common in bilharzia patients, with nearly 18% testing positive for HCV. Egyptian patients showed the highest HCV prevalence among those with schistosomiasis.
Area of Science:
- Hepatology
- Infectious Diseases
- Parasitology
Background:
- Hepatitis C virus (HCV) and Schistosoma mansoni co-infection contribute significantly to chronic liver disease and cirrhosis.
- Understanding the prevalence of HCV in patients with schistosomiasis is crucial for public health management.
Purpose of the Study:
- To determine the prevalence of Hepatitis C virus (HCV) infection among patients diagnosed with bilharziasis (schistosomiasis).
Main Methods:
- Sera from 405 patients with suspected bilharziasis were tested for HCV using ELISA and for Schistosoma infestation using indirect hemagglutination.
- Schistosomiasis diagnosis was confirmed by an anti-schistosoma antibody titer of 1:256 or higher.
Main Results:
- Of 405 patients, 39 (9.6%) tested positive for bilharzia antibodies.
- Among those with bilharzia, 7 patients (17.9%) showed evidence of HCV infection.
- HCV prevalence was highest among Egyptian patients (26.7%) compared to Saudis (11.8%) and other Middle Eastern nationals (14.3%).
Conclusions:
- A significant proportion of patients with bilharziasis are co-infected with Hepatitis C virus.
- HCV prevalence is notably higher in Egyptian patients with schistosomiasis.
- These findings highlight the importance of screening for HCV in bilharzia patients, particularly in endemic regions.
Objective:
Hepatitis C virus (HCV) infection with concurrent Schistosoma mansoni infestation has emerged as a major cause of chronic liver disease and liver cirrhosis. The aim of this study was to investigate the prevalence of HCV among bilharzia patients.
Methods:
The study was conducted at the Viral Diagnostic and Parasitology Departments, Regional Laboratory and Blood Bank, Dammam, Kingdom of Saudi Arabia from August 1999 to July 2000. Sera from a total of 405 patients, including 356 Saudi nationals and 49 non-Saudis, who had a clinical suspicion of bilharziasis were tested, using enzyme linked immunosorbent assay for HCV infection and indirect hemagglutination tests for Schistosoma infestation. Diagnosis of schistosomiasis was made when serum anti-schistosoma antibody titer was either equal to or more than 1:256.
Results:
A total of 39 cases out of 405 tested positive for bilharzia antibodies comprising of 22 (44.9%) non-Saudi and 17 (4.8%) Saudi individuals. Among these patients 7(17.9%) were found to have evidence of HCV infection. Of the 7 patients tested positive for HCV antibodies, there were 4 (26.7%) Egyptians, 2 (11.8%) Saudis and one (14.3%) Middle-Eastern.
Conclusion:
Our data shows that a good proportion (17.9%) of patients with bilharziasis had HCV infection. The percentage positive for HCV antibody were 26.7% in Egyptians, which is higher when compared to other nationals and Saudis.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Yellow Fever
Amebiasis
Poliomyelitis
Genital Herpes
